| 08:50-09:00 |
Opening remarks |
대한치매학회장 |
| |
Treating Alzheimer's disease with monoclonal antibodies, updates |
좌장: 이재홍 (울산의대)
박기형 (가천의대) |
| 09:00-09:20 |
Gantenerumab_ Update on Gantenerumab |
Tobias Bittner
(Distinguished Scientist, Roche Diagnostics) |
| 09:20-09:40 |
Lecanemab_ Lecanemab for the Treatment of Early Alzheimer’s Disease: Results from the Clarity AD Phase 3 Study |
Michael Irizarry
(Vice President, Eisai Inc) |
| 09:40-10:00 |
Donanemab_ TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer’s Disease |
Stephane Epelbaum
(Associate Vice President, Lilly International) |
| 10:00-10:20 |
Coffee Break |
|
Plenary session I |
좌장: 최성혜 (인하의대) |
| 10:20-11:20 |
한국 신경심리검사의 발전사 및 치매의 진단과 치료에 대한 적용 |
강연욱 (한림대 심리학과) |
| |
Plenary session II |
좌장: 양동원 (가톨릭의대) |
| 11:20-12:20 |
A clinicogenetic spectrum among personality trait, psychiatric disease and FTD |
Yolande Pijnenburg (Amsterdam University Medical Center, Netherlands) |
| 12:20-13:00 |
총회 및 Lunch |
| 13:00-14:00 |
Poster Presentation |
|
| |
Oral Presentation A |
좌장: 서상원 (성균관의대)
박영호 (서울의대) |
|
Oral Presentation B |
좌장: 심용수 (가톨릭의대)
윤보라 (건양의대) |
| 14:00-14:12 |
Frontotemporal dementia and motor neuron disease spectrum in Annexin A11 variants |
김승현 (한양대학교병원) |
14:00-14:12 |
The emerging role of vascular burden in AT(N) classification in individuals with Alzheimer’s and concomitant cerebrovascular burdens |
전민영 (용인세브란스병원) |
| 14:12-14:24 |
Transcriptional risk score in Alzheimer's disease: from pathology to cognition |
편정민 (순천향대학교 서울병원) |
14:12-14:24 |
Dietary Intake of n-6 Polyunsaturated Fatty Acid is Associated with Alzheimer’s Disease Pathology in a Memory Clinic Population |
김해원 (계명대학교 동산병원) |
| 14:24-14:36 |
Predicting cognitive stage transition using p-tau181, Centiloid, and other measures |
고성호 (한양대학교 구리병원) |
14:24-14:36 |
Effect of Internet-based vs in-person cognitive interventions on patients with mild to moderate Alzheimer’s disease: A randomized, cross-over, open-label trial |
정영희 (한양대학교 명지병원) |
| 14:36-14:48 |
Gender-Specific Relationship Between Thigh Muscle and Fat Mass and Amyloid Positivity |
강성훈 (고려대학교 구로병원) |
14:36-14:48 |
Real-world one-year estimation of the candidates for Lecanemab in a South Korean memory clinic |
이한 (아주의대 의학과) |
| 14:48-15:00 |
Progranulin haploinsufficiency mediates TDP43 cytoplasmic aggregation with lysosomal dysfunction in the human model of microglia. |
성원재 (한양대학교병원) |
14:48-15:00 |
VR-EP-EEG-MRI digital biomarkers: Multi-modal machine learning model for detecting mild cognitive impairment |
최호진 (한양대학교 구리병원) |
| 15:00-15:10 |
Coffee Break |
| |
C9orf72: ethnic difference or missed in Korean population? |
좌장: 김승현 (한양의대)
김은주 (부산의대) |
|
Preventive and therapeutic approaches for Alzheimer's disease : Preclinical |
좌장: 이건호 (조선대)
정용 (KAIST) |
| 15:10-15:40 |
C9orf72: probably ethnic difference? |
김영은 (한양의대) |
15:10-15:30 |
Preventive and therapeutic effects of Korean red ginseng polysaccharides on Alzheimer’s disease |
문민호 (건양대) |
| 15:40-16:10 |
C9orf72: probably missed? |
문소영 (아주의대) |
15:30-15:50 |
Alzheimer's Disease and Synaptic plasticity; A New Protection Strategy |
조지훈 (전남대) |
| 15:50-16:10 |
Targeting P.gingivalis as a new AD protection strategy |
김윤경 (KIST 뇌과학연구소) |
| |
Neural correlates and Management of NBSD |
좌장: 송홍기 (한림의대)
유희진 (건국대병원) |
|
Ethical & legal issues in dementia |
좌장: 정산 (한림의대)
정지향 (이화의대) |
| 16:10-16:30 |
Neural correlates of NBSD |
임재성 (울산의대) |
16:10-16:40 |
치매 환자와 연관된 윤리적 문제 |
나해리 (보바스기념병원) |
| 16:30-16:50 |
Pharmacological management of NBSD |
이찬녕 (고려의대) |
16:40-17:10 |
치매 환자와 연관된 법적 분쟁 사례 |
함철성 (서준 법률사무소) |
| 16:50-17:10 |
Non-pharmacological management of BPSD |
송준아 (고려대 간호학과) |
| 17:10-17:30 |
Closing Remarks 및 시상식 |
